Centre Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17,702
| Closed | -$2.74M | – | 61 |
|
|
2023
Q4 | $2.74M | Sell |
17,702
-2,341
| -12% | -$341K | 0.66% | 42 |
|
|
2023
Q3 | $2.99M | Sell |
20,043
-698
| -3% | -$102K | 0.73% | 41 |
|
|
2023
Q2 | $2.79M | Buy |
20,741
+683
| +3% | +$100K | 0.62% | 46 |
|
|
2023
Q1 | $3.2M | Buy |
20,058
+317
| +2% | +$48.5K | 0.77% | 47 |
|
|
2022
Q4 | $3.19M | Buy |
19,741
+331
| +2% | +$50.8K | 0.84% | 46 |
|
|
2022
Q3 | $2.6M | Buy |
19,410
+22
| +0.1% | +$3.16K | 0.72% | 45 |
|
|
2022
Q2 | $2.97M | Buy |
+19,388
| New | +$2.96M | 0.79% | 38 |
|
|
2022
Q1 | – | Sell |
-27,585
| Closed | -$3.73M | – | 62 |
|
|
2021
Q4 | $3.73M | Buy |
+27,585
| New | +$3.26M | 1.89% | 22 |
|
|
2018
Q4 | – | Sell |
-52,640
| Closed | -$4.98M | – | 64 |
|
|
2018
Q3 | $4.98M | Sell |
52,640
-2,960
| -5% | -$281K | 1.16% | 45 |
|
|
2018
Q2 | $5.15M | Sell |
55,600
-3,590
| -6% | -$351K | 1.21% | 43 |
|
|
2018
Q1 | $5.6M | Buy |
59,190
+3,470
| +6% | +$381K | 1.29% | 41 |
|
|
2017
Q4 | $5.39M | Buy |
+55,720
| New | +$5.25M | 1.31% | 38 |
|
|
2017
Q1 | – | Sell |
-80,500
| Closed | -$5.04M | – | 49 |
|
|
2016
Q4 | $5.04M | Buy |
+80,500
| New | +$4.91M | 0.97% | 48 |
|
|
2016
Q3 | – | Sell |
-8,130
| Closed | -$503K | – | 62 |
|
|
2016
Q2 | $503K | Hold |
8,130
| – | – | 0.09% | 71 |
|
|
2016
Q1 | $464K | Sell |
8,130
-3,550
| -30% | -$198K | 0.08% | 70 |
|
|
2015
Q4 | $692K | Sell |
11,680
-147,730
| -93% | -$8.51M | 0.12% | 62 |
|
|
2015
Q3 | $8.67M | Sell |
159,410
-9,890
| -6% | -$644K | 1.5% | 33 |
|
|
2015
Q2 | $11.4M | Sell |
169,300
-4,271
| -2% | -$279K | 1.79% | 17 |
|
|
2015
Q1 | $10.2M | Buy |
173,571
+42,981
| +33% | +$2.6M | 1.51% | 31 |
|
|
2014
Q4 | $8.55M | Buy |
130,590
+1,040
| +0.8% | +$65.6K | 1.32% | 37 |
|
|
2014
Q3 | $7.48M | Buy |
129,550
+25,530
| +25% | +$1.42M | 1.15% | 36 |
|
|
2014
Q2 | $5.87M | Sell |
104,020
-20,820
| -17% | -$1.09M | 0.88% | 59 |
|
|
2014
Q1 | $6.42M | Sell |
124,840
-44,590
| -26% | -$2.25M | 0.95% | 52 |
|
|
2013
Q4 | $8.95M | Buy |
169,430
+16,270
| +11% | +$800K | 1.39% | 31 |
|
|
2013
Q3 | $6.85M | Buy |
153,160
+37,290
| +32% | +$1.65M | 1.09% | 36 |
|
|
2013
Q2 | $4.79M | Buy |
+115,870
| New | +$5.07M | 0.78% | 47 |
|
Other funds holding ABBV
Centre Asset Management's ABBV Position: Q1 2024 in Review
Centre Asset Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 17,702 shares — an estimated $2.74M sold.
Centre Asset Management first reported a position in ABBV in Q2 2013 and held it in 26 quarters. The position peaked at $11.4M in Q2 2015. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Centre Asset Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
- Centre Asset Management sold 17,702 AbbVie shares in Q1 2024, an estimated $2.74M.
- Centre Asset Management first reported a position in AbbVie in Q2 2013 and held it in 26 quarters.
- Centre Asset Management's AbbVie position peaked at $11.4M in Q2 2015.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Centre Asset Management's 13F filing for Q1 2024, filed 2 Apr 2024.